Literature DB >> 16849359

Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.

P Brun, I Castagliuolo, A R Floreani, A Buda, L Blasone, G Palù, D Martines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16849359      PMCID： PMC1856285          DOI： 10.1136/gut.2006.093336

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Sp1 is a critical factor for the monocytic specific expression of human CD14.

Authors:  D E Zhang; C J Hetherington; S Tan; S E Dziennis; D A Gonzalez; H M Chen; D G Tenen
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

3.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 4.  Is obesity an inflammatory condition?

Authors:  U N Das
Journal:  Nutrition       Date:  2001 Nov-Dec       Impact factor: 4.008

5.  Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells.

Authors:  Paola Brun; Ignazio Castagliuolo; Massimo Pinzani; Giorgio Palù; Diego Martines
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-04-28       Impact factor: 4.052

6.  Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.

Authors:  H A Järveläinen; A Orpana; M Perola; V T Savolainen; P J Karhunen; K O Lindros
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

7.  Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Authors:  Yong-Han Paik; Robert F Schwabe; Ramón Bataller; Maria P Russo; Christian Jobin; David A Brenner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

8.  Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis.

Authors:  Chikako Namikawa; Zhang Shu-Ping; John Raynor Vyselaar; Yasuko Nozaki; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisawa; Toshiji Saibara; Makoto Hiroi; Hideaki Enzan; Saburo Onishi
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

9.  Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682
  9 in total
  11 in total

Review 1.  Genetic and epigenetic mechanisms of NASH.

Authors:  Mohammed Eslam; Jacob George
Journal:  Hepatol Int       Date:  2015-12-18       Impact factor: 6.047

Review 2.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

3.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

4.  CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Daisuke Satoh; Takahito Yagi; Takeshi Nagasaka; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utsumi; Takehiro Tanaka; Hiroshi Sadamori; Toshiyoshi Fujiwara
Journal:  World J Hepatol       Date:  2013-04-27

5.  Heritability of nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Manuel A Celedon; Joel E Lavine; Rany Salem; Nzali Campbell; Nicholas J Schork; Masoud Shiehmorteza; Takeshi Yokoo; Alyssa Chavez; Michael S Middleton; Claude B Sirlin
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

Review 6.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

7.  Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.

Authors:  Kayleigh L Wood; Michael H Miller; John F Dillon
Journal:  BMJ Open Gastroenterol       Date:  2015-02-17

8.  Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis.

Authors:  Takaomi Kessoku; Kento Imajo; Yasushi Honda; Takayuki Kato; Yuji Ogawa; Wataru Tomeno; Shingo Kato; Hironori Mawatari; Koji Fujita; Masato Yoneda; Yoji Nagashima; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

9.  Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease.

Authors:  Shweta Kapil; Ajay Duseja; Bal Krishan Sharma; Bhupesh Singla; Anuradha Chakraborti; Ashim Das; Pallab Ray; Radha K Dhiman; Yogesh Chawla
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

Review 10.  Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?

Authors:  Roger W Chapman; Kate D Williamson
Journal:  Curr Hepatol Rep       Date:  2017-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.